Search

As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side effects, including allergic reactions and long-term consequences, are the public’s top concern about getting vaccinated when asked to describe what worries them in their own words. The latest report from…

This chart collection draws on primary and secondary data analyses by KFF and other sources to examine the characteristics, experiences, and outcomes of the Medicare population by race and ethnicity

In the January report from the COVID-19 Vaccine Monitor, the lack of information around where and when to get the COVID-19 vaccine is particularly pronounced among Hispanic and Black adults compared to White Adults. Learn more in this Chart of the Week.

Thirty-one percent of the public wants to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. While they share a similar level of vaccine hesitancy, this group is not monolithic in their attitudes and beliefs. This brief examines how people with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and may respond differently to messages and information.

In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system, examine the major programs that…

Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations. The latest analysis from the KFF COVID-19 Vaccine Monitor highlights how attitudes differ by…

This brief shows trends in hospital admissions during the coronavirus pandemic. Admissions to hospitals for reasons other than COVID-19 fell markedly again in November 2020 as cases of infections with the novel coronavirus began to surge anew, suggesting that more people were delaying care due to the worsening pandemic.

During the 55th week since the first coronavirus case appeared in the United States, the world is at nearly 108 million COVID-19 cases. The U.S. approached 27.4 million cases and a total of 475,400 deaths.

This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.

This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.